Ossiam’s 10x Genomics TXG Stock Holding History

Ossiam’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-229,300	Closed	-$4.87M	–	715
2026 Q1	$4.87M	Hold	229,300	–	–	0.09%	106
2025 Q4	$3.74M	Hold	229,300	–	–	0.07%	127
2025 Q3	$2.68M	Buy	+229,300	New	+$2.99M	0.03%	289

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ossiam's TXG Position: Q2 2026 in Review

Ossiam sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 229,300 shares — an estimated $4.87M sold.

Ossiam first reported a position in TXG in Q3 2025 and held it in 3 quarters. The position peaked at $4.87M in Q1 2026. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Ossiam reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
Ossiam sold 229,300 10x Genomics shares in Q2 2026, an estimated $4.87M.
Ossiam first reported a position in 10x Genomics in Q3 2025 and held it in 3 quarters.
Ossiam's 10x Genomics position peaked at $4.87M in Q1 2026.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.